Journal of Histochemistry and Cytochemistry, Vol. 47, 1351-1356, November 1999, Copyright © 1999, The Histochemical Society, Inc.
VEGF and Vascular Fusion: Implications for Normal and Pathological Vessels
Christopher J. Drakea and
Charles D. Littlea
a Department of Cell Biology and the Cardiovascular Developmental Biology Center, Medical University of South Carolina, Charleston, South Carolina
Correspondence to:
Charles D. Little, Dept of Cell Biology, BSB626, Medical Univ of South Carolina, 173 Ashley Ave., Charleston, SC 29425.
The avian embryo is well suited for the study of blood vessel morphogenesis. This is especially true of investigations that focus on the de novo formation of blood vessels from mesoderm, a process referred to as vasculogenesis. To examine the cellular and molecular mechanisms regulating vasculogenesis, we developed a bioassay that employs intact avian embryos. Among the many bioactive molecules we have examined, vascular epithelial growth factor (VEGF) stands out for its ability to affect vasculogenesis. Using the whole-embryo assay, we discovered that VEGF induces a vascular malformation we refer to as hyperfusion. Our studies showed that microinjection of recombinant VEGF165 converted the normally discrete network of embryonic blood vessels into enlarged endothelial sinuses. Depending on the amount of VEGF injected and the time of postinjection incubation, the misbehavior of the primordial endothelial cells can become so exaggerated that for all practical purposes the embryo contains a single enormous vascular sinus; all normal vessels are subsumed into a composite vascular structure. This morphology is reminiscent of the abnormal vascular sinuses characteristic of certain neovascular pathologies. (J Histochem Cytochem 47:13511355, 1999)
Key Words:
vasculogenesis, vascular fusion, VEGF, vascular hyperfusion

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. A. Rupp, R. P. Visconti, A. Czirok, D. A. Cheresh, and C. D. Little
Matrix Metalloproteinase 2-Integrin {alpha}v{beta}3 Binding Is Required for Mesenchymal Cell Invasive Activity but Not Epithelial Locomotion: A Computational Time-Lapse Study
Mol. Biol. Cell,
December 1, 2008;
19(12):
5529 - 5540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Purpura, S. H.L. George, S. M. Dang, K. Choi, A. Nagy, and P. W. Zandstra
Soluble Flt-1 Regulates Flk-1 Activation to Control Hematopoietic and Endothelial Development in an Oxygen-Responsive Manner
Stem Cells,
November 1, 2008;
26(11):
2832 - 2842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M.S. van den Akker, V. Caolo, L. J. Wisse, P. P.W.M. Peters, R. E. Poelmann, P. Carmeliet, D. G.M. Molin, and A. C. Gittenberger-de Groot
Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling
Cardiovasc Res,
May 1, 2008;
78(2):
366 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Holderfield and C. C.W. Hughes
Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-{beta} in Vascular Morphogenesis
Circ. Res.,
March 28, 2008;
102(6):
637 - 652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Davis and D. R. Senger
Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization
Circ. Res.,
November 25, 2005;
97(11):
1093 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. LIU and D. R. SENGER
Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells
FASEB J,
March 1, 2004;
18(3):
457 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Hoang, M. C. Whelan, and D. R. Senger
Rho activity critically and selectively regulates endothelial cell organization during angiogenesis
PNAS,
February 17, 2004;
101(7):
1874 - 1879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Whelan and D. R. Senger
Collagen I Initiates Endothelial Cell Morphogenesis by Inducing Actin Polymerization through Suppression of Cyclic AMP and Protein Kinase A
J. Biol. Chem.,
January 3, 2003;
278(1):
327 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ren, L. H. Michael, M. L. Entman, and N. G. Frangogiannis
Morphological Characteristics of the Microvasculature in Healing Myocardial Infarcts
J. Histochem. Cytochem.,
January 1, 2002;
50(1):
71 - 80.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X. Yue and R. J. Tomanek
Effects of VEGF165 and VEGF121 on vasculogenesis and angiogenesis in cultured embryonic quail hearts
Am J Physiol Heart Circ Physiol,
May 1, 2001;
280(5):
H2240 - H2247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Drake and P. A. Fleming
Vasculogenesis in the day 6.5 to 9.5 mouse embryo
Blood,
March 1, 2000;
95(5):
1671 - 1679.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 1999
|
|
|